Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin-Alexander Bollmann (Hannover, Germany), Benjamin-Alexander Bollmann, Benjamin Seeliger, Jens Gottlieb, Mark Greer. Risk of post-transplantation diabetes mellitus (PTDM) with different calcineurin inhibitors. Eur Respir J 2016; 48: Suppl. 60, 4646

Member's Comments

No comment yet.

Related content which might interest you: Impact of diabetes mellitus on survival and hospitalization after lung transplantation Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Impact of diabetes mellitus on MDR-TB outcome Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Hyperglycemia and diabetes mellitus as mortality risk factors in 600 COVID-19 Romanian patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity) Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 A study of immunogenetic markers associated With tuberculosis and diabetes mellitus Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Impact of diabetes mellitus (dm) or hypertension and ischaemic heart disease (hd) on cisplatin nephrtotoxicity Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Smoking cessation in patients with Diabetes Mellitus (DM) Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020 Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients Source: Eur Respir J 2011; 37: 888-894 Year: 2011